Calamos Advisors LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,523,000
+0.0%
2,423,0000.0%0.01%0.0%
Q4 2021$2,522,000
-4.6%
2,423,0000.0%0.01%
-25.0%
Q3 2021$2,644,000
-0.2%
2,423,0000.0%0.01%0.0%
Q2 2021$2,648,000
+0.9%
2,423,0000.0%0.01%
-14.3%
Q1 2021$2,625,000
-0.1%
2,423,0000.0%0.01%
-6.7%
Q4 2020$2,628,000
+4.6%
2,423,0000.0%0.02%
-6.2%
Q3 2020$2,513,000
-1.5%
2,423,0000.0%0.02%
-11.1%
Q2 2020$2,550,000
+1.3%
2,423,0000.0%0.02%
-10.0%
Q1 2020$2,517,000
-11.6%
2,423,0000.0%0.02%
+42.9%
Q4 2019$2,846,000
+17.5%
2,423,0000.0%0.01%
+7.7%
Q3 2019$2,423,000
-71.7%
2,423,000
-69.7%
0.01%
-72.9%
Q2 2019$8,566,000
-3.0%
8,000,0000.0%0.05%
-12.7%
Q1 2019$8,828,000
+16.9%
8,000,0000.0%0.06%
+10.0%
Q4 2018$7,553,000
-69.7%
8,000,000
-58.1%
0.05%
-63.5%
Q3 2018$24,956,000
-1.7%
19,115,000
+0.0%
0.14%
-11.6%
Q2 2018$25,382,000
+12.1%
19,109,000
+0.0%
0.16%
+5.4%
Q1 2018$22,652,000
+0.7%
19,103,000
-0.4%
0.15%
+27.8%
Q4 2017$22,484,000
-5.0%
19,174,000
-3.4%
0.12%
-37.2%
Q3 2017$23,659,000
-30.1%
19,852,000
-21.1%
0.18%
-26.8%
Q2 2017$33,870,000
-7.4%
25,165,000
-13.9%
0.25%
-13.2%
Q1 2017$36,586,000
+7.6%
29,230,000
-1.3%
0.29%
+6.7%
Q4 2016$33,996,000
-5.4%
29,610,000
-1.0%
0.27%
+5.1%
Q3 2016$35,930,000
+22.1%
29,924,000
+5.1%
0.26%
+24.8%
Q2 2016$29,422,00028,467,0000.21%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Context Capital Management, LLC 1,000,000$1,164,0000.58%
CSS LLC/IL 7,044,000$8,236,0000.46%
WOLVERINE ASSET MANAGEMENT LLC 33,392,000$39,039,0000.45%
DeepCurrents Investment Group LLC 5,056,000$5,872,0000.26%
SSI INVESTMENT MANAGEMENT LLC 3,175,000$3,696,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 5,000,000$5,850,0000.17%
LINDEN ADVISORS LP 10,269,000$12,015,0000.14%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,817,000$2,126,0000.11%
HBK INVESTMENTS L P 10,116,000$11,822,0000.11%
LAZARD ASSET MANAGEMENT LLC 16,000,000$18,783,0000.03%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders